-
-
-
-
-
-
-
Maze Therapeutics names Hervé Hoppenot as board chairman
-
-
-
-
-
-
-
Bicycle Therapeutics plc (BCYC) Misses Q1 EPS by 3c
-
-
-
-
-
-
-
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
-
-
-
-
-
-
-
Bicycle Therapeutics plc (BCYC) Misses Q2 EPS by 21c
-
-
-
-
-
-
-
Bicycle Therapeutics plc (BCYC) Misses Q3 EPS by 7c
-
-
-
-
-
-
-
Needham & Company Reiterates Bicycle Therapeutics (BCYC) at Buy, Focus Remains on BT8009
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

